Lung Cancer Considered

The IASLC World Conference on Lung Cancer will be held in person this year in Vienna. Lung Cancer Considered Hosts Dr. Narjust Florez and Dr. Stephen Liu preview the meeting highlights and provide advice on how to plan your own experience and what scientific sessions might be the most interesting. This podcast episode is a must listen for all in person attendees and those participating virtually from their home or office.

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of the unique challenges women in oncology face as they navigate career pathways. She is joined by Dr. Prunella Blinman, a medical oncologist at Concord Repatriation General Hospital in Sydney, Australia and clinical associate professor at the University of Sydney. Also joining the discussion is Dr. Clarissa Mathias, medical oncologist and director of NOB/Oncoclinicas in Brazil. She is a member of the ASCO International Quality Steering Group and Lung cancer committee and she served on the IASLC board of directors.

In keeping with IASLC's international focus, this episode of Lung Cancer Considered focuses on the state of lung cancer in Germany. This episode is hosted by Dr. Alessandra Curioni, Thoracic Medical Oncologist at the University of Zurich and her guests are two of the most prominent lung cancer experts in Germany -- Dr. Martin Reck, Head of the Department of Thoracic Oncology and the Head of the Clinical Trials Department at the Lung Clinic Grosshansdorf and Dr. Juergen Wolf, Medical Director for the Center for Integrated Oncology at the University Hospital Cologne.

This episode of Lung Cancer Considered examines the state of lung cancer care and research in South Africa. Joining host Dr. Stephen Liu is Dr. Ronwyn van Eeden, a medical oncologist practicing in Rosebank, South Africa. Dr. van Eeden has just started her own oncology unit and is also an honorary consultant in medical oncology at the Chris Hani Baragwanath Academic Hospital.

Dr. Marina Garassino and Dr. Suresh Ramalingam join Lung Cancer Considered host Dr. Narjust Florez to share experiences as international medical graduates.

Dr. Garassino is an internationally recognized expert in the treatment of thoracic malignancies from the Medical School of Università degli Studi of Milan, Italy, She recently joined the University of Chicago as the chief of the Thoracic Oncology Group.

Dr. Suresh Ramalingam is the Executive Director, Winship Cancer Institute of Emory University, the Roberto C. Goizueta Distinguished Chair for Cancer Research, and a professor of medicine at Emory University School of Medicine.

In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss the recently completed ASCO meeting with colleagues Dr. Catherine Shu and Dr. Jack West. Dr. Shu is a board-certified medical oncologist specializing in the treatment of thoracic cancers, especially lung cancer, at Columbia University's Herbert Irving Comprehensive Cancer Center. Dr. West is a medical oncologist at City of Hope Cancer Center and is the founder of the Global Resource for Advancing Cancer Education, a nonprofit organization dedicated to providing timely, free, credible information to patients and caregivers around the world.

What are Antibody Drug Conjugates, and do they have a promising future in lung cancer treatment? To discuss this topic, Lung Cancer Considered host Dr. Stephen Liu is joined by Dr. Rebecca Heist, associate director of clinical research at Massachusetts General Hospital Cancer Center in Boston, and Dr. Ben Levy, clinical director of medical oncology at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center in Baltimore.

India is an extremely diverse and populous country with just under 1.5 billion people. And as with every country in the world, lung cancer represents a major threat to public health. In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks about the state of lung cancer in India with Dr. Navneet Singh, Professor in the Department of Pulmonary Medicine at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh, India.

Providing smoking cessation without contributing to the stigma faced by those who smoke is a worthwhile goal. To discuss this in greater detail, Lung Cancer Considered host Dr. Narjust Duma welcomes Dr. Jamie Ostroff, Dr. Matthew Steliga, and Jim Pantelas. Dr. Ostroff is the Joseph Gaumont Chair of Cancer Prevention and the Director of the Memorial Sloan Kettering Tobacco Treatment Program and Dr. Steliga is an Associate Professor in Surgery at the University of Arkansas Medical Center and a member and past chair of the IASLC Tobacco control and smoking cessation committee. Mr. Jim Pantelas is a patient advocate and activist who collaborates with organizations like the Lung Cancer Research Foundation (formerly known as Free to Breathe) and the Lung Cancer Alliance.

Dr. Hilary Robbins, an epidemiologist with the International Agency for Research on Cancer, and Dr. Brendon Stiles, chief of Thoracic Surgery and Surgical Oncology at Montefiore-Einstein Cancer Center in New York, join Lung Cancer Considered host Dr. Stephen Liu to discuss the current status of lung cancer screening research and challenges to implementing it on a national and international scale.